Therapeutic landscape in advanced non small cell lung. Features the monostable spool valves in conformity with iec 61508 standard 2010 route 2. Pemetrexed delays lung cancer progression medpage today. Fellow publications bedano pm, perkins s, burns m, kessler k, nelson r, schneider b, risley l, dropcho s, loehrer pj. As an example, in a hoosier oncology group study, 47 previously treated patients received singleagent pemetrexed. Pemetrexed continuation improves overall survival in nsclc. Antitumor activity of histone deacetylase hdac inhibitors in this disease has been documented, including one patient with thymoma treated with the panhdac inhibitor belinostat. Locally advanced thymoma and thymic carcinoma require a multimodality treatment approach with a combination of surgery, chemotherapy, and radiation therapy to decrease the chances of recurrence and improve survival. Jun 10, 2011 the 359 patients on pemetrexed did not progress for a median of 4. As a result, a phase ii trial was initiated to evaluate the clinical activity of pemetrexed in previously treated patients with thymoma thy and thymic carcinoma.
Jul 11, 20 the paramount study was the first large trial to demonstrate that continuation maintenance therapy can increase progressionfree survival in the setting of advanced nonsquamous nsclc. Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck article pdf available in british journal of cancer 855. Although previous trials demonstrated the efficacy and safety of postoperative cisplatinbased adjuvant chemotherapy for. Downloaded from by journals press access on june 25, 2018 from 162. Each ml of the concentrate for solution for infusion contains 25 mg of pemetrexed as 30. Clinical guidelines and practical recommendations for the prevention of cinv are published and regularly updated by several cancer associations such as multinational association of supportive care in cancer mascc, european society for medical oncology esmo, and american society of clinical oncology asco. Given that the cost of raltitrexed is approximately 15% of the cost of pemetrexed alimta, the committee concluded that pemetrexed alimta did not demonstrate good valueformoney. Jun 03, 2009 pemetrexed extends survival in patients with advanced nonsquamous nonsmallcell lung cancer, but whether the chemotherapy should be used as maintenance or secondline therapy is a matter of debate.
Data from a phase ii study support the use of pemetrexed in previously treated unresectable advanced thymoma or thymic carcinoma loehrer 2006. Aug 22, 2018 provides accurate and independent information on more than 24,000 prescription drugs, overthecounter medicines and natural products. Asco annual meeting proceedings abstr 7079j clin oncol. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Sixteen thymoma and 11 thymic carcinoma patients were treated and among 23 evaluable patients, there were two crs and two prs in thymoma patients but none in thymic carcinoma patients. Pemetrexed extends survival in advanced lung cancer. Patients and methods this was a singlearm, singlestage, open. Please note that although condensed summary information is.
Alimta pemetrexed for injection is a folate analog metabolic inhibitor. Obesity asco guidelines for appropriate chemotherapy dosing in. Results of a phase ii study of pemetrexed as firstline. Pemetrexed 8 disodium heptahydrate has the chemical name lglutamic acid, n422amino4,7dihydro4. Pdf pemetrexed safety and pharmacokinetics in patients with.
Presented by gilberto lopes at 2018 asco annual meeting. A phase ii trial of erlotinib plus bevacizumab in patients with recurrent thymoma or thymic carcinoma. Similar results were presented at asco 2008 by brade et al 25 and gadgeel et al 26. Pemetrexed, a multitargeted antifolate, has shown activity in previously treated patients. Pemetrexed is widely used for the treatment of advanced nonsquamous nonsmallcell lung cancer nsclc. Review of pemetrexed in combination with cisplatin for the.
Without pemetrexed n 106 age sex enrollment region ecog ps histology smoking status treated brain metastases chemotherapy regimen 0. Treatment advances in locally advanced and metastatic nonsmall. Pdf pemetrexed for the treatment of nonsmall cell lung cancer. Preliminary results of phase ii study of capecitabine and. Pronunciation of pemetrexed with 2 audio pronunciations, 2 translations and more for pemetrexed. A phase ii trial of pemetrexed in patients with recurrent. Few prospective trials have been conducted in patients with advance thymic malignancies. What pemetrexed 25 mgml concentrate for solution for infusion contains the active substance is pemetrexed. Treatment of advanced thymoma and thymic carcinoma springerlink. Pemetrexed a multitargeted antifolate with a broad range of clinical activity, but previously untested in thymic malignancies. Ive been involved with the thymoma research since the early 1980s, since i was a fellow, and i continue to do this to present day. Lorusso d, ferrandina g, pignata s, et al, evaluation of pemetrexed alimta, ly231514 as secondline.
Asco s targeted agent and profiling utilization registry tapur study is a nonrandomized clinical trial aiming to describe the performance of commercially available, targeted anticancer drugs prescribed for treatment of patients with advanced cancer with a potentially actionable genomic variant. Final appraisal determination pemetrexed maintenance treatment following induction therapy with pemetrexed and cisplatin for nonsquamous nonsmallcell lung cancer issue date. Phase ii study of everolimus in patients with thymoma. Apr 21, 2009 the mainstay of therapy is complete surgical resection. Highlights of prescribing information these highlights do not include all the information needed to use alimta safely and effectively. A read is counted each time someone views a publication summary such as the title, abstract, and list of authors, clicks on a figure, or views or downloads the fulltext.
Biology and treatment of thymoma giuseppe giaccone m. This study evaluated the activity of everolimus in patients with advancedrecurrent t or tc previously treated with cisplatincontaining chemotherapy. Pemetrexed in patients with thymic malignancies previously. Gbolahan ob1, porter rf2, salter jt3, yiannoutsos c4, burns m2, chiorean eg5, loehrer pj sr6.
Although the effect of third space fluid is not fully defined, studies have determined pemetrexed concentrations in patients with mildtomoderate ascitespleural effusions were similar to concentrations in trials of patients without third space fluid accumulation. A phase ii study of pemetrexed in patients with recurrent thymoma. Results of a phase ii study of pemetrexed as firstline chemotherapy in patients with advanced or metastatic breast cancer article in breast cancer research and treatment 1261. Pemetrexed interactions bnf content published by nice. Pemetrexed safety and pharmacokinetics in patients with thirdspace fluid article pdf available in clinical cancer research 1610. Dec 19, 2016 while the claims of lillys ep 1 3 508 b1 specifically require pemetrexed disodium, amtiris comprises pemetrexed diacid. Corticosteroids, the oldest agent in the prevention of. Vitamin b12 and folate reduce toxicity of alimta pemetrexed disodium, ly231514, mta, a novel antifolateantimetabolite. Pemetrexed and cisplatin with concurrent radiotherapy. Pemetrexed maintenance treatment following induction therapy. Aug 28, 2001 this phase ii study determined response rate of patients with locally advanced or metastatic head and neck cancer treated with pemetrexed disodium, a new multitargeted antifolate that inhibits. Purpose in keynote189, firstline pembrolizumab plus pemetrexed platinum significantly improved overall survival os and progressionfree survival pfs compared with placebo plus pemetrexed platinum in patients with metastatic nonsquamous non. Loehrer pj, yiannoutsos ct, dropcho s, et al, a phase ii trial of pemetrexed in patients with recurrent thymoma or thymic carcinoma, j clin oncol, 2006, 24suppl.
Our group has previously conducted a study in 16 patients with advanced pretreated tets with octreotide associated with prednisone. Dec 14, 2017 purpose no effective salvage treatments are available for patients with advancedrecurrent thymoma t or thymic carcinoma tc who have progressed after platinumbased chemotherapy. Measles, mumps and rubella vaccine, live is predicted to increase the risk of generalised infection possibly lifethreatening when given with pemetrexed. Pemetrexed disodium in recurrent locally advanced or. Results of the phase ii study evaluating the role of pemetrexed in patients with recurrent tets. I am a medical oncologist and director of the indiana university melvin and bren simon cancer center in the united states. Preliminary results of phase ii study of capecitabine and gemcitabine capgem in patients with metastatic pretreated thymic epithelial tumors tets. Asco guidelines for appropriate chemotherapy dosing in obese adults with. This phase ii study determined response rate of patients with locally advanced or metastatic head and neck cancer treated with pemetrexed.
Patients received pemetrexed 500 mgm2, carboplatin area under the concentrationtime curve of. Pemetrexed disodium in recurrent locally advanced or metastatic. We compared the clinical and molecule pathological characteristics of good and poor responders among a cohort of 1,848 nonsquamous nsclc patients who had received at least two cycles of. Apr 18, 2011 purpose thymic epithelial tumors are rare malignancies, and there is no standard treatment for patients with advanced disease in whom chemotherapy has failed. The fpc held that limitation from antifolate to pemetrexed disodium during prosecution constitutes an abandonment of subjectmatter. Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma.
Riely is an oncologist in new york, new york and is affiliated with one hospital. The objective response rate was 28 percent, including three complete responses 6 percent. A phase ii study of pemetrexed in patients with recurrent. Preliminary results of phase ii study of capecitabine and gemcitabine. However, factors that can predict the benefits of pemetrexed therapy have not yet been defined.
But even if it would not be considered an abandonment, the fpc denied an infringement. It is also important to note that not many trials have been published in pretreated tets with chemotherapy and the most active regimens, used in this setting, were octreotide and pemetrexed 15. Pdf pemetrexed disodium in recurrent locally advanced or. A phase ii study of pemetrexed in patients with recurrent thymoma and thymic carcinoma. Loehrer pj, yiannoutsos ct, dropcho s, et al a phase ii trial of pemetrexed in patients with recurrent thymoma or thymic carcinoma. S p e c i a l s e r v i ce p i l ot 1 32 series 362562 visit our website at asco. J clin oncol 2006, asco annual meeting proceedings. Folic acid 400 mcg daily orally begin 7 days prior to treatment initiation. Jun 03, 2019 alimta pemetrexed for injection, for intravenous use. Pemetrexed for the treatment of nonsmall cell lung cancer. The drug substance, pemetrexed disodium heptahydrate, has the chemical name lglutamic acid, n422amino4,7dihydro4oxo1hpyrrolo2,3dpyrimidin5ylethylbenzoyl, disodium salt, heptahydrate with a molecular formula of c 20 h 19 n 5 na 2 o. Patients and methods patients with advanced thymic. Pemetrexed potently inhibits ts, dhfr, and garft as well as aicarft but with a lesser potency and exhibits autitumor activity in a broad range of tumors, including nonsmall cell lung carcinoma, malignant mesothelioma, and carcinomas of the breast, colorectum, uterine cervix, head and neck, and bladder. The 4 ml vial contains either 100 mg of pemetrexed as 120.
1240 413 1639 1482 806 1659 686 1368 753 502 1082 1023 1278 1438 1091 1396 738 1151 704 1100 887 1294 516 375 1481 434 1425 697 15 988 1348 1284 290 790 538 1231 91 1361 1153 736 417 695